SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-465620
Filing Date
2016-02-16
Accepted
2016-02-16 17:06:30
Documents
2
Group Members
JONATHAN A. FLINTKEVIN BITTERMANPOLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS FUND V, L.P.POLARIS VENTURE PARTNERS SPECIAL FOUNDERS FUND V, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d120159dsc13da.htm SC 13D/A 132470
2 EX-99.A d120159dex99a.htm EX-99.A 11053
  Complete submission text file 0001193125-16-465620.txt   145458
Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Subject) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87984 | Film No.: 161430060
SIC: 2836 Biological Products, (No Diagnostic Substances)